Login
$NUAI
$3.25 +$0.28 (9.43%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Current Assets
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Prepaid expenses and other current assets
Related party receivable
Restricted investments
Total Current Assets
Oil and natural gas properties, net
Property and equipment, net
Land
Investment in Joint Venture
Prepaid expenses - non-current
Total Assets
Current Liabilities
Accounts payable
Accrued liabilities
Excise taxes payable
Withholding taxes payable
Note payable
Notes payable - current
Convertible note, net of discount – current
Embedded derivative liability - Current
Due to related parties
Asset retirement obligation - current
Embedded derivative liability
Other liabilities - current
Nonrelated party
Related Party
Total other liabilities - current
Total Current Liabilities
Embedded derivative liability
Note payable, net
Asset retirement obligation
Total Liabilities
Stockholders’ Equity (Deficit)
Common stock, $0.0001 par value, 245,000,000 shares authorized, 106,665,286 issued and 106,490,928 outstanding at June 30, 2026; 53,623,529 issued and 53,449,171 outstanding at December 31, 2025
Treasury stock, 174,358 shares at June 30, 2026 and December 31, 2025
Additional Paid-in Capital
Accumulated deficit
Total Stockholders’ Equity (Deficit)
Total Liabilities and Stockholders’ Equity (Deficit)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support